| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Temsirolimus |
|---|
| Description | mTOR inhibitor; inhibits tumor growth in breast cancer cell lines (IC50 values are 1.6 and 4.3 nM for SKBr3 and BT474, respectively). Inhibits HIF-1α-mediated VEGF production in breast cancer cell lines (BT474 and MDA-MB-231). Directly inhibits serum and VEGF mediated endothelial cell proliferation and morphogenesis in vitro and vessel formation in vivo. Causes G1/S cell cycle arrest in multiple cancer cell lines. Antiangiogenic. Activates autophagy. Purity 98%. MW (observed): 1030.29 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate]. CCI-779 |
|---|
| Gene, Accession, CAS # | CAS: 162635-04-3 |
|---|
| Catalog # | 5264/10 |
|---|
| Price | |
|---|
| Order / More Info | Temsirolimus from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 29930108 |
|---|
| 產(chǎn)品資料 |
|
|